PARADEEP · Chemicals
Paradeep Phosphates Ltd. reported revenue of ₹4,702 cr for January to March 2026, +12.1% on the year and −18.2% on the quarter. Over the last four quarters revenue comes to ₹21,827 cr, +34.9% on the four before.
Operating profit (EBITDA) was ₹442 cr, a margin of 9.4%, +27 bps on the year and +119 bps on the quarter. Over the last 8 quarters the margin has ranged from 6.1% to 12.9%, averaging 9.4%. Operating costs grew +11.8% against revenue growth of +12.1%, so more of each rupee of sales reached operating profit.
Net profit was ₹156 cr, −9.3% on the year and −14.3% on the quarter, with earnings per share of ₹1.50. Profit before other income, one-offs and tax fell 10.1%, so the profit growth came from the business itself. The tax rate was 23% against an average of 29% over the previous 8 quarters, which lifted profit this quarter. Profit over the last four quarters totals ₹997 cr, +55.5% on the four before.
Speciality chemicals are read on volumes and pricing, with Chinese supply a recurring swing factor; inventory destocking can hit a quarter without a change in demand. The quarterly statements do not carry volumes against prices, capacity utilisation and new molecules; those come with the filing read.
On earnings per share of ₹11.32 over the last four quarters, the stock at ₹147.22 trades at 13.0 times trailing earnings.
Written from the quarterly statements. The filing read adds the balance sheet and cash flow filed with this quarter, the auditor's review, segment results, one-off items line by line and what management said on the call.
No check fired. That is a statement about the checks below, not a verdict on the company.
Could not run on this quarter: Exceptional items that recur, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).
Net profit a year ago, each driver's change, and net profit now. Blue added profit, red took it away.
This quarter's filing carries a balance sheet and a cash flow statement. The cash, receivables and borrowing checks run once the filing read is in.
| Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,595 cr | ₹2,243 cr | ₹2,377 cr | ₹4,619 cr | ₹4,990 cr | ₹4,194 cr | ₹4,504 cr | ₹6,872 cr | ₹5,749 cr | ₹4,702 cr | ₹6,124 cr | ₹7,364 cr |
| YoY | — | — | −22% | +25% | +92% | +87% | +89% | +49% | +15% | +12% | +36% | +7% |
| EBITDA margin | 10.9% | 6.6% | 6.1% | 11.0% | 8.8% | 9.1% | 12.9% | 9.6% | 8.2% | 9.4% | 11.8% | 5.6% |
| Other income, % of PBT | 6% | 119% | 146% | 6% | 15% | 25% | 8% | 9% | −4% | 21% | 8% | 11% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 29% | 18% | 59% | 24% | 28% | 28% | 25% | 27% | 22% | 23% | 25% | 26% |
| Net profit | ₹109 cr | ₹22.0 cr | ₹5.0 cr | ₹255 cr | ₹209 cr | ₹172 cr | ₹317 cr | ₹342 cr | ₹182 cr | ₹156 cr | ₹393 cr | ₹121 cr |
| YoY | — | — | — | +187% | +92% | +682% | +6,240% | +34% | −13% | −9% | +24% | −65% |
| Core profit YoY | — | — | — | +191% | +70% | — | — | +35% | −2% | −10% | +24% | −66% |
| EPS | ₹1.34 | ₹0.26 | ₹0.07 | ₹3.13 | ₹2.57 | ₹2.11 | ₹3.88 | ₹4.19 | ₹1.75 | ₹1.50 | ₹3.78 | ₹1.17 |
| Flags | · | 1 | 1 | ✓ | 1 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 1 |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Paradeep Phosphates Ltd. reported revenue of ₹4,702 cr (+12.1% on the year) and net profit of ₹156 cr (−9.3% on the year) for January to March 2026.
Profit before other income, exceptional items and tax moved −10.1% on the year, against −9.3% for reported profit.
None of the 7 checks that could run raised a question.
No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.